1. Home
  2. KD vs XENE Comparison

KD vs XENE Comparison

Compare KD & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kyndryl Holdings Inc.

KD

Kyndryl Holdings Inc.

HOLD

Current Price

$13.52

Market Cap

2.8B

Sector

Technology

ML Signal

HOLD

XENE

Xenon Pharmaceuticals Inc.

HOLD

Current Price

$54.50

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KD
XENE
Founded
2020
1996
Country
United States
Canada
Employees
80000
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
KD
XENE
Price
$13.52
$54.50
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$25.92
$68.55
AVG Volume (30 Days)
3.4M
781.0K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
170.95
N/A
EPS
0.77
N/A
Revenue
$15,057,000,000.00
$311,000.00
Revenue This Year
$3.73
N/A
Revenue Next Year
$0.08
$2,496.48
P/E Ratio
$17.76
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$28.19
52 Week High
$43.74
$62.91

Technical Indicators

Market Signals
Indicator
KD
XENE
Relative Strength Index (RSI) 49.47 45.16
Support Level $12.03 $52.55
Resistance Level $13.81 $56.66
Average True Range (ATR) 0.55 1.72
MACD 0.04 -0.80
Stochastic Oscillator 51.78 19.06

Price Performance

Historical Comparison
KD
XENE

About KD Kyndryl Holdings Inc.

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives. The company's reportable segments consist of the following: Principal Markets which represents its operations in operations in Australia / New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, and the United Kingdom / Ireland, United States, Japan, and Strategic Markets. It derives maximum revenue from the United States.

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

Share on Social Networks: